Moderna
MRNA
$59.05
Share price
-0.94%
Change (1 day)
-67.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Total debt
Total debt on the balance sheet as of December 2024 : NZ$1.30 Billion
According to Moderna 's latest financial reports the company's total debt is NZ$1.30 Billion. A company’s total debt is the sum of all current and non-current debts.
Moderna - Total debt on balance sheet (from 2017 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$1.32 B | -32.61% |
| 2023-12-31 | NZ$1.96 B | 3.99% |
| 2022-12-31 | NZ$1.89 B | 40.94% |
| 2021-12-31 | NZ$1.34 B | 308.28% |
| 2020-12-31 | NZ$0.32 B | 67.13% |
| 2019-12-31 | NZ$0.19 B | 293.66% |
| 2018-12-31 | NZ$49.92 M | 126.03% |
| 2017-12-31 | NZ$22.08 M | 22.4% |
| 2016-12-31 | NZ$18.04 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | NZ$0.47 M | -99.96% | 🇺🇸 USA |
 | NZ$64.73 B | 4,868.01% | 🇺🇸 USA |
 | NZ$32.4 M | -97.51% | 🇺🇸 USA |
 | NZ$2.26 B | 73.50% | 🇺🇸 USA |
 | NZ$54.52 B | 4,084.47% | 🇨🇭 Switzerland |
 | NZ$0.91 B | -29.68% | 🇺🇸 USA |
 | NZ$63.90 B | 4,804.15% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |